Elevance Health, Inc.

For the period ended Jun 30, 2026. Filed Jul 15, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 15, 2026

ELV$429.65+2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Income (Unaudited) for the and

Consolidated Statements of Income

	Three Months Ended June 30		Six Months Ended June 30
	2026	2025	2026	2025
(In millions, except per share data)
Revenues
Premiums	$41,279	$41,271	$82,303	$82,158
Product revenue	6,264	6,042	12,489	11,851
Service fees	2,283	2,108	4,528	4,177
Total operating revenue	49,826	49,421	99,320	98,186
Net investment income	704	486	1,469	1,076
Net losses on financial instruments	(56)	(131)	(134)	(595)
Total revenues	50,474	49,776	100,655	98,667
Expenses
Benefit expense	37,024	36,706	72,639	72,018
Cost of products sold	5,492	5,293	10,955	10,276
Operating expense	5,547	4,997	11,877	10,297
Interest expense	364	341	721	685
Amortization of other intangible assets	110	147	222	302
Total expenses	48,537	47,484	96,414	93,578
Income before income tax expense	1,937	2,292	4,241	5,089
Income tax expense	483	548	1,027	1,161
Net income	1,454	1,744	3,214	3,928
Net loss (gain) attributable to noncontrolling interests	9	(1)	13	(2)
Shareholders’ net income	$1,463	$1,743	$3,227	$3,926
Shareholders’ net income per share
Basic	$6.74	$7.74	$14.78	$17.39
Diluted	$6.71	$7.72	$14.73	$17.33
Dividends per share	$1.72	$1.71	$3.44	$3.42

-3-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.